Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Takeda Acquires Rights To Amgen Drugs
February 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Japanese firm Takeda is to develop and commercialise up to 13 molecules from US-based Amgen's pipeline for its domestic market. Amgen will receive US$200mn upfront, US$702mn in milestone payments and double-digit royalties on sales. Ownership of Amgen's subsidiary in Japan will be also transferred to Takeda.